{"id":"https://openalex.org/W2886048414","doi":"https://doi.org/10.1158/1538-7445.am2018-1829","title":"Abstract 1829: PRAS40 as a mediator of insulin-like growth factor-1 receptor-induced resistance to epidermal growth factor receptor inhibition in head and neck cancer","display_name":"Abstract 1829: PRAS40 as a mediator of insulin-like growth factor-1 receptor-induced resistance to epidermal growth factor receptor inhibition in head and neck cancer","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2886048414","doi":"https://doi.org/10.1158/1538-7445.am2018-1829","mag":"2886048414"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-1829","doi":"https://doi.org/10.1158/1538-7445.am2018-1829","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-1829","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076362284","display_name":"Michael I. Dougherty","orcid":"https://orcid.org/0000-0003-3682-336X","observed_orcids":["https://orcid.org/0000-0003-3682-336X"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael I. Dougherty","raw_affiliation_strings":["1University of Virginia, Charlottesville, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Virginia, Charlottesville, VA;","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046183492","display_name":"Christine E. Lehman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine E. Lehman","raw_affiliation_strings":["1University of Virginia, Charlottesville, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Virginia, Charlottesville, VA;","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044032013","display_name":"Rolando E. Mendez","orcid":"https://orcid.org/0000-0003-3335-2347","observed_orcids":["https://orcid.org/0000-0003-3335-2347"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rolando E. Mendez","raw_affiliation_strings":["1University of Virginia, Charlottesville, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Virginia, Charlottesville, VA;","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023901142","display_name":"Linnea E. Taniguchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linnea E. Taniguchi","raw_affiliation_strings":["1University of Virginia, Charlottesville, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Virginia, Charlottesville, VA;","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110689423","display_name":"Julie Wulfkuhle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Wulfkuhle","raw_affiliation_strings":["2George Mason University, Manassas, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2George Mason University, Manassas, VA","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023762376","display_name":"Emanuel F. Petricoin","orcid":"https://orcid.org/0000-0001-9146-5572","observed_orcids":["https://orcid.org/0000-0001-9146-5572"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emanuel F. Petricoin","raw_affiliation_strings":["2George Mason University, Manassas, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2George Mason University, Manassas, VA","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089350105","display_name":"Daniel G. Gioeli","orcid":"https://orcid.org/0000-0003-2284-8152","observed_orcids":["https://orcid.org/0000-0003-2284-8152"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel G. Gioeli","raw_affiliation_strings":["1University of Virginia, Charlottesville, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Virginia, Charlottesville, VA;","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082940788","display_name":"Mark J. Jameson","orcid":"https://orcid.org/0000-0002-7414-2779","observed_orcids":["https://orcid.org/0000-0002-7414-2779"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Jameson","raw_affiliation_strings":["1University of Virginia, Charlottesville, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Virginia, Charlottesville, VA;","institution_ids":["https://openalex.org/I51556381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"1829","last_page":"1829"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.5375999808311462,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.5375999808311462,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.30809998512268066,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.05169999971985817,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pras40","display_name":"PRAS40","score":0.9929999709129333},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9620000123977661},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9100000262260437},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8360000252723694},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.824999988079071},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.6520000100135803},{"id":"https://openalex.org/keywords/foxo3","display_name":"FOXO3","score":0.949999988079071},{"id":"https://openalex.org/keywords/p70s6k","display_name":"p70S6K","score":0.9869999885559082},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.9440000057220459},{"id":"https://openalex.org/keywords/anti-apoptotic-pathways","display_name":"anti-apoptotic pathways","score":0.7099999785423279},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.3610000014305115},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.3440000116825104},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5509999990463257},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.654748797416687},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6436893939971924},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.6398927569389343},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.627312421798706},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.6050358414649963},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5917004346847534},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5112783908843994},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.4850984811782837},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4838387072086334},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.44664815068244934},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.31020933389663696},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.28623509407043457},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25883445143699646},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.22924306988716125},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.09537851810455322},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06489366292953491},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-1829","doi":"https://doi.org/10.1158/1538-7445.am2018-1829","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-1829","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3032234624","https://openalex.org/W2112609258","https://openalex.org/W2254809110","https://openalex.org/W2248980631","https://openalex.org/W2118981054","https://openalex.org/W2083818892","https://openalex.org/W2110290265","https://openalex.org/W2969850455","https://openalex.org/W3143680120","https://openalex.org/W2320041709"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"Despite":[2],"the":[3,8,83,159,216,220,284,373],"known":[4],"growth-promoting":[5],"role":[6,84,270],"of":[7,59,85,213,222,286,308,312,352,372],"epidermal":[9,359],"growth":[10,36,354,360],"factor":[11,361],"receptor":[12,38,362],"(EGFR)":[13],"in":[14,31,49,70,87,162,188,215,249,264,273,281,319,364],"head":[15,365],"and":[16,106,113,141,153,366],"neck":[17,367],"squamous":[18],"cell":[19,116,128,164,190,195,321],"carcinoma":[20],"(HNSCC),":[21],"EGFR":[22,47,92,136,170,231,257,294],"tyrosine":[23],"kinase":[24],"inhibitors":[25],"(TKIs)":[26],"have":[27,182],"shown":[28,42],"low":[29],"efficacy":[30],"this":[32,206],"disease.":[33],"The":[34],"insulin-like":[35,353],"factor-1":[37,355],"(IGF-1R)":[39],"has":[40,315],"been":[41,316],"to":[43,46,75,91,109,124,204,227,236,289,358],"induce":[44],"resistance":[45,90,357],"TKIs":[48],"HNSCC":[50,127,250],"predominantly":[51],"through":[52,306],"anti-apoptotic":[53],"pathways.":[54],"PRAS40":[55,69,86,151,166,186,241,278,348],"is":[56,174,243,262,305],"an":[57,76,224,230,297],"inhibitor":[58],"mTOR":[60,214,282,287],"that":[61,252,314],"ceases":[62],"inhibition":[63,137,288,307,363],"upon":[64],"phosphorylation":[65,152,167,173,187,201,242,279],"by":[66,138,176],"Akt.":[67],"Phosphorylated":[68],"turn":[71],"inhibits":[72],"FOXO3a,":[73,309],"contributing":[74],"overall":[77],"pro-survival":[78],"state.":[79],"This":[80,260],"study":[81],"evaluates":[82],"IGF-1R":[88,139,177],"mediated":[89],"TKIs.":[93],"METHODS:":[94],"In":[95,192],"vitro":[96],"experiments":[97],"using":[98],"alamarBlue,":[99],"CyQuant,":[100],"reverse":[101],"phase":[102],"protein":[103,111],"microarray":[104],"(RPPA),":[105],"immunoblot":[107],"techniques":[108],"evaluate":[110],"expression/phosphorylation":[112],"correlate":[114],"with":[115,169,229,246],"physiologic":[117],"behavior.":[118],"RESULTS:":[119],"Proliferation":[120],"assays":[121],"were":[122],"used":[123],"separate":[125],"6":[126],"lines":[129],"into":[130],"2":[131],"groups:":[132],"those":[133,142],"rescued":[134,163],"from":[135,197,256,293],"activation":[140,248],"not":[143,234],"rescued.":[144],"RPPA":[145,160],"analysis":[146,157],"identified":[147],"a":[148,193,268,310,350],"correlation":[149],"between":[150],"rescue":[154,217,255,292],"status.":[155],"Immunoblot":[156],"confirmed":[158],"findings:":[161],"lines,":[165],"decreases":[168],"inhibition,":[171],"but":[172],"restored":[175],"activation.":[178],"However,":[179],"these":[180],"treatments":[181],"little":[183],"effect":[184],"on":[185],"non-rescued":[189,265],"lines.":[191],"representative":[194],"line":[196],"each":[198],"group,":[199],"p70S6K":[200],"was":[202,233],"found":[203],"follow":[205],"pattern":[207],"as":[208,349],"well,":[209],"suggesting":[210,267],"possible":[211,303],"involvement":[212],"mechanism.":[218],"However":[219],"addition":[221],"temsirolimus,":[223],"mTORC1":[225],"inhibitor,":[226],"treatment":[228],"TKI":[232,258],"sufficient":[235],"overcome":[237,290],"IGF-induced":[238,291],"rescue.":[239],"CONCLUSIONS:":[240],"tightly":[244],"correlated":[245],"IGF1R":[247],"cells":[251],"exhibit":[253],"IGF1R-induced":[254],"treatment.":[259],"phenomenon":[261],"absent":[263],"cells,":[266],"potential":[269],"for":[271,376],"pPRAS40":[272,313],"IGF1R-based":[274],"therapeutic":[275],"resistance.":[276],"While":[277],"results":[280],"activation,":[283],"inability":[285],"antagonism":[295],"suggests":[296],"important":[298],"alternative":[299],"downstream":[300],"pathway.":[301],"One":[302],"mechanism":[304],"function":[311],"previously":[317],"reported":[318],"other":[320],"types.":[322],"Citation":[323],"Format:":[324],"Michael":[325],"I.":[326],"Dougherty,":[327],"Christine":[328],"E.":[329,332,335],"Lehman,":[330],"Rolando":[331],"Mendez,":[333],"Linnea":[334],"Taniguchi,":[336],"Julie":[337],"Wulfkuhle,":[338],"Emanuel":[339],"F.":[340],"Petricoin,":[341],"Daniel":[342],"G.":[343],"Gioeli,":[344],"Mark":[345],"J.":[346],"Jameson.":[347],"mediator":[351],"receptor-induced":[356],"cancer":[368],"[abstract].":[369],"In:":[370],"Proceedings":[371],"American":[374],"Association":[375],"Cancer":[377,390],"Research":[378],"Annual":[379],"Meeting":[380],"2018;":[381],"2018":[382],"Apr":[383],"14-18;":[384],"Chicago,":[385],"IL.":[386],"Philadelphia":[387],"(PA):":[388],"AACR;":[389],"Res":[391],"2018;78(13":[392],"Suppl):Abstract":[393],"nr":[394],"1829.":[395]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-08-22T00:00:00"}